Get the Stockscreener App
21.64
0.05%
0.01
Avadel Pharmaceuticals Plc stock is traded at $21.64, with a volume of 35.02M.
It is up +0.05% in the last 24 hours and up +0.65% over the past month.
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.
See More
Previous Close:
$21.63
Open:
$21.66
24h Volume:
35.02M
Relative Volume:
14.65
Market Cap:
$2.12B
Revenue:
$221.08M
Net Income/Loss:
$-2.92M
P/E Ratio:
-655.76
EPS:
-0.033
Net Cash Flow:
$5.89M
1W Performance:
+0.19%
1M Performance:
+0.65%
6M Performance:
+61.49%
1Y Performance:
+142.87%
1-Day Range:
$21.63
$21.76
1-Week Range:
$21.59
$21.76
52-Week Range:
$6.38
$23.57
Avadel Pharmaceuticals Plc Stock (AVDL) Company Profile
Name
Avadel Pharmaceuticals Plc
Sector
Phone
636-449-1830
Address
10 EARLSFORT TERRACE, DUBLIN 2
Compare AVDL vs TAK, ZTS, HLN, TEVA, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AVDL
Avadel Pharmaceuticals Plc
|
21.64 | 2.12B | 221.08M | -2.92M | 5.89M | -0.033 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.32 | 57.75B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
127.90 | 56.70B | 9.40B | 2.65B | 2.24B | 5.935 |
|
HLN
Haleon Plc Adr
|
11.16 | 49.70B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
33.86 | 39.96B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
477.16 | 20.49B | 3.13B | 1.27B | 1.12B | 26.39 |
Avadel Pharmaceuticals Plc Stock (AVDL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-23-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Sep-03-25 | Initiated | Wells Fargo | Equal Weight |
| Jul-18-25 | Resumed | H.C. Wainwright | Buy |
| Feb-11-25 | Initiated | Deutsche Bank | Buy |
| Jun-12-24 | Initiated | Rodman & Renshaw | Buy |
| Mar-05-24 | Reiterated | H.C. Wainwright | Buy |
| Mar-05-24 | Reiterated | Needham | Buy |
| Mar-05-24 | Reiterated | Oppenheimer | Outperform |
| Feb-06-24 | Initiated | UBS | Buy |
| Nov-30-22 | Upgrade | Jefferies | Hold → Buy |
| Aug-10-22 | Downgrade | Jefferies | Buy → Hold |
| Jul-28-22 | Resumed | Craig Hallum | Buy |
| May-26-22 | Downgrade | Stifel | Buy → Hold |
| Sep-23-21 | Initiated | Needham | Buy |
| Jul-31-20 | Initiated | Oppenheimer | Outperform |
| Jul-21-20 | Initiated | SVB Leerink | Outperform |
| Jun-30-20 | Initiated | H.C. Wainwright | Buy |
| Apr-03-20 | Initiated | Jefferies | Buy |
| Mar-12-20 | Initiated | Stifel | Buy |
| Feb-26-20 | Initiated | Piper Sandler | Overweight |
| Jan-30-20 | Initiated | Craig Hallum | Buy |
| Jun-14-19 | Upgrade | Ladenburg Thalmann | Neutral → Buy |
| Feb-08-19 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
View All
Avadel Pharmaceuticals Plc Stock (AVDL) Latest News
Alkermes plc Completes Acquisition of Avadel Pharmaceuticals plc, Accelerating Entry Into Sleep Medicine Market - BioSpace
Alkermes PLC Completes Acquisition Of Avadel Pharmaceuticals PLC, Accelerating Entry Into Sleep Medicine Market - TradingView
Alkermes Acquires Avadel Pharmaceuticals - Contract Pharma
Form 8.3Avadel Pharmaceuticals plc - The Manila Times
Alkermes Completes Acquisition and Delisting of Avadel Pharmaceuticals - TipRanks
Avadel Pharmaceuticals Announced Transfer or Voluntary Withdrawal of Listing - TradingView
Alkermes (Nasdaq: ALKS) closes Avadel acquisition, adds LUMRYZ and $1.5B loans - Stock Titan
(AVDL) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Growth Recap: Is Avadel Pharmaceuticals plc stock a falling knife or bargain buyQuarterly Earnings Report & Weekly Market Pulse Alerts - baoquankhu1.vn
Form 8.3 -Avadel Pharmaceuticals plc - The Manila Times
Irish High Court sanctions Avadel Pharmaceuticals acquisition by Alkermes - TipRanks
Alkermes (ALKS) Set to Finalize Acquisition of Avadel Pharmaceuticals - GuruFocus
Avadel Pharmaceuticals plc Announces High Court Approval of Scheme of Arrangement for Acquisition by Alkermes plc - Quiver Quantitative
Avadel Pharmaceuticals Announces Outcome of the Court Sanction Hearing - The Manila Times
Irish court clears Alkermes buyout; Avadel stock trading ends Feb. 11 - Stock Titan
Alkermes Increases Offer for Avadel Acquisition - MSN
Penserra Capital Management LLC Buys New Holdings in Avadel Pharmaceuticals PLC. $AVDL - MarketBeat
Goldman Sachs (EPT)Form 38.5b- AVADEL PHARMACEUTICALS PLC - Research Tree
Market Review: Is Avadel Pharmaceuticals plc vulnerable to short sellersJuly 2025 Reactions & Long-Term Safe Investment Plans - baoquankhu1.vn
Avadel Pharmaceuticals PLC. (NASDAQ:AVDL) Sees Large Increase in Short Interest - MarketBeat
Macro Review: Will CMBT outperform tech stocksEarnings Beat & Community Shared Stock Ideas - baoquankhu1.vn
Bank of America discloses 2.39% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
Responsive Playbooks and the AVDL Inflection - Stock Traders Daily
Avadel Pharmaceuticals PLC. (NASDAQ:AVDL) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Is Avadel Pharmaceuticals plc on track to beat earningsEarnings Beat & Reliable Breakout Forecasts - Mfd.ru
Alkermes stock price target raised to $47 from $46 at UBS on Avadel deal - Investing.com Nigeria
Alkermes stock price target raised to $47 from $46 at UBS on Avadel deal By Investing.com - Investing.com India
Swing Trade: Will ChargePoint Holdings Inc benefit from seasonalityJuly 2025 Action & Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Avadel Pharmaceuticals (NASDAQ:AVDL) Shares Pass Above 200 Day Moving AverageTime to Sell? - MarketBeat
Understanding the Setup: (AVDL) and Scalable Risk - Stock Traders Daily
Avadel Sets Court Date for Alkermes Acquisition Scheme - TipRanks
Avadel Pharmaceuticals Announces Court Hearing for Acquisition - TradingView — Track All Markets
Avadel (NASDAQ: AVDL) moves Alkermes acquisition forward with Irish court hearing date - Stock Titan
Avadel Pharmaceuticals appoints Susan Rodriguez as COO - MSN
State Street Increases Stake in Avadel Pharmaceuticals by 2.39% - intellectia.ai
BlackRock discloses 6.94% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
Janus Henderson discloses 1.87% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
Morgan Stanley discloses trading activity in Avadel Pharmaceuticals shares By Investing.com - Investing.com Nigeria
Bank of America discloses 1.3% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
TIG Advisors discloses 4.18% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
Goldman Sachs discloses trading position in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
Avadel Pharmaceuticals (AVDL) Investor Outlook: Navigating a 54.90% Revenue Growth Amidst a Hold-Heavy Consensus - DirectorsTalk Interviews
BlackRock discloses 6.94% stake in Avadel Pharmaceuticals - Investing.com
TIG Advisors discloses 4.18% stake in Avadel Pharmaceuticals - Investing.com
Janus Henderson discloses 1.87% stake in Avadel Pharmaceuticals - Investing.com India
Avadel Pharmaceuticals Plc Stock (AVDL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.53%
10.58%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):